NIH-funded research NIH-funded research

Identifying factors that predict severe COVID-19 in children

Official title: Severity Predictors Integrating salivary Transcriptomics and proteomics with Multi neural network Intelligence in SARS-CoV2 infection in Children (SPITS MISC)

Funded at Central Michigan University · NIH-10847809 · Data updated 2026-11-12

This study is looking at how certain markers in saliva can help doctors figure out which kids with COVID-19 might get really sick, so they can get the help they need sooner.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCentral Michigan University
NIH-funded
Lab location1 site (Mount Pleasant, United States)
Project startJanuary 1, 2021
Project endNovember 30, 2025
Funding year2023
Award (this year)$735,747
NIH project number3R33HD105610-03S1
Project IDNIH-10847809 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are children aged 0-21 who have been exposed to SARS-CoV-2.

Less likely to help

Patients who have not been exposed to SARS-CoV-2 or are over 21 years old may not benefit from this research.

What this research studies

This research investigates how certain biological markers in saliva can help predict which children infected with SARS-CoV-2 are at risk of developing severe illness, such as Multisystem Inflammatory Syndrome (MIS-C). By analyzing these markers alongside social and clinical health factors, the study aims to create a model that can identify children who may need early intervention. The approach includes collecting saliva samples and using advanced artificial intelligence techniques to analyze the data. The ultimate goal is to improve health outcomes for children affected by COVID-19.

Why it matters

Potential benefit: If successful, this research could lead to earlier identification and treatment for children at risk of severe COVID-19 complications.

How similar studies have gone: Other research has shown promise in using biomarkers to predict disease severity in various conditions, suggesting that this approach may be effective.

Where this research is happening

  • Central Michigan University
    Mount Pleasant, United States
    Active

Researchers

  • Principal investigator: Sethuraman, Usha — Central Michigan University
  • Study coordinator: Sethuraman, Usha

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.